Product Information
SAXAGLIPTIN HCL 5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $1.1176 per EA under NDC 65862082690. Its NADAC has been published 30 times since Dec 3, 2025.
Strength
5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862082690
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SAXAGLIPTIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205972On Market Since
7/31/2023
Pharmacological Classes
Price Statistics
The NADAC for SAXAGLIPTIN HCL 5 MG TABLET has been published 30 times since Dec 3, 2025, and over the history we have for it it has declined 61.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1176 per EA |
|---|---|
| All-time high | $2.9076 (Dec 10, 2025) |
| All-time low | $1.1176 (Jun 17, 2026) |
| 52-week high | $2.9076 |
| 52-week low | $1.1176 |
| Median price | $1.4682 |
| Average price | $1.7164 |
| Largest weekly change | -25.9% (Feb 18, 2026) |
| Weeks tracked | 30 |
| Tracking since | Dec 3, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SAXAGLIPTIN HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SAXAGLIPTIN HCL 5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $1.1176 per EA (NDC 65862082690), effective Jun 24, 2026.
How has the price of SAXAGLIPTIN HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for SAXAGLIPTIN HCL 5 MG TABLET has declined 61.6%. It has been tracked across 30 weekly CMS publications since Dec 3, 2025.
What are the highest and lowest recorded NADAC prices for SAXAGLIPTIN HCL 5 MG TABLET?
Since Dec 3, 2025, the NADAC for SAXAGLIPTIN HCL 5 MG TABLET has ranged from a low of $1.1176 (Jun 17, 2026) to a high of $2.9076 (Dec 10, 2025), with a median of $1.4682 per EA.
Are there cheaper alternatives to SAXAGLIPTIN HCL 5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as SAXAGLIPTIN HCL 5 MG TABLET, but none are currently priced below it.
Who manufactures SAXAGLIPTIN HCL 5 MG TABLET?
SAXAGLIPTIN HCL 5 MG TABLET (NDC 65862082690) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification